NCT00654160View on ClinicalTrials.gov

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

November 30, 2010

Study Completion Date

December 3, 2012

Conditions
Anal CancerCarcinoma of the AppendixColorectal CancerEsophageal CancerExtrahepatic Bile Duct CancerGallbladder CancerGastric CancerGastrointestinal Carcinoid TumorGastrointestinal Stromal TumorLiver CancerPancreatic CancerSmall Intestine Cancer
Interventions
DRUG

fluorouracil

DRUG

irinotecan hydrochloride

DRUG

leucovorin calcium

OTHER

pharmacogenomic studies

OTHER

pharmacological study

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER